Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination antiretroviral therapy

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 403-404

  Sadler, M ^a,b,c   Moyle, G J ^a,b   Buss, N ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ROCHE PRODUCTS LTD   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE ANALOG; RITONAVIR; SAQUINAVIR;

ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0033008145     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517200     Document Type: Article

References (5)

1. 1. Foudraine NA, Hoetelmans R, Lange JMA, et al. Cerebrospinal fluid (CSF) HIV-RNA and drug concentrations during treatment with lamivudine (3TC) in combination with zidovudine (AZT) or stavudine (d4T). Lancet 1998;351:1547-51.
2. 1a.Moyle G. The role of combinations of HIV protease inhibitors in the management of persons with HIV infection. Expert Opinion of Investigational Drugs 1998;7:413-26.
3. 2. Groll A, Giri N, Gonzalez T, et al. Penetration of lipid formulations of amphotericin B into cerebrospinal fluid and brain tissue [abstract no A-90]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
4. 3. Thomas SA, Segal MB. Blood-to-central nervous system entry of 2′, 3′-didehydro-3′-deoxythymidine and 3′-azido,3′-deoxythymidine [abstract no 464]. In: Program and abstracts of the 6th European Conference on Clinical Aspects of Treatment of HIV Infection (Hamburg, Germany). 1997.
5. 4. Farthing C, Japour A, Cohen C, et al. Cerebrospinal fluid (CSF) and plasma HIV RNA suppression with ritonavir (RIT) - saquinavir (SQV) in protease inhibitor naïve patients [abstract no LB-3]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.